Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Operating Margin (2024 - 2025)

Indivior Pharmaceuticals has reported Operating Margin over the past 2 years, most recently at 22.63% for Q4 2025.

  • Quarterly results put Operating Margin at 22.63% for Q4 2025, up 724.0% from a year ago — trailing twelve months through Dec 2025 was 21.13% (up 1793.0% YoY), and the annual figure for FY2025 was 21.15%, up 1795.0%.
  • Operating Margin for Q4 2025 was 22.63% at Indivior Pharmaceuticals, up from 13.69% in the prior quarter.
  • Over the last five years, Operating Margin for INDV hit a ceiling of 26.41% in Q1 2024 and a floor of 39.46% in Q2 2024.